Elsa Ronzier joined the Biomedical Research Laboratory (BRL) within the Institute for Biohealth Innovation in July 2024 as an Infectious Disease Research Faculty.
At the BRL, Dr. Ronzier is using cell culture, organ on-a-chip technology and animal models coupled with confocal and SEM imaging, genomic & biochemistry techniques and flow cytometry to study host-pathogen interactions, cell signaling, endocytosis mechanisms, exosome production, immune cell activation and inflammation in order to support therapeutic discoveries and novel biomaterial development.
During her PhD and post-doctoral trainings, Elsa Ronzier studied ion channel post-translational modifications and trafficking in plant and animal models. She also studied on macrophage activation during inflammatory stimulation to better understand immunological dysfunctions and actinopathies. Since 2021, as a Cell and Molecular Biologist, Dr. Ronzier deciphered the early cellular signaling responses to traumatic injuries to understand and prevent organ dysfunctions after injuries and then studied protein trafficking and quality control in order to comprehend neurodegenerative diseases.